Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 28, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 28, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 28, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 28, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 3, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 2, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 2, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 2, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 5, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 26, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 29, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Nov 29, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 29, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 31, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 31, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 11, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 25, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 23, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 30, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 4, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products, namely, multifunctional molecules that promote binding to immune cells and disease cells or organisms, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Class 042
Discovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Classification
International Classes
005
042